Last updated on August 2019

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies


Brief description of study

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02390 in participants with select advanced malignancies.

Clinical Study Identifier: NCT03652077

Find a site near you

Start Over

University of Mississippi

Jackson, MS United States
  Connect »

Carolina BioOncology

Huntsville, NC United States
  Connect »

Hackensack Medical Center

Hackensack, NJ United States
  Connect »